The health hazard evaluation isn't the record
Under 21 CFR 7.41, FDA — not the firm — assigns a device recall its Class I, II, or III severity, built on an internal Health Hazard Evaluation. The enforcement record this product watches carries the resulting number and the firm's own reason for recall. It was never built to carry the evaluation that produced the number.
By Connor Griggs — Regulatory & Quality Strategist
A device recall’s classification — Class I, II, or III — reads like a firm’s own judgment about how serious its problem is. It isn’t. Under 21 CFR 7.3(m), classification is FDA’s own numerical designation of the relative degree of health hazard a product presents, and FDA assigns it, not the firm that initiated the recall. The document that determination rests on has a name, and that name never shows up in the record a monitoring feed actually reads.
One regulation, three tiers, one evaluator
21 CFR 7.41(a) directs FDA to weigh a set of named factors — whether a hazard has already caused injury, the degree of seriousness, and the probability that an existing condition will actually produce harm, among others — to decide whether a recalled product is Class I (reasonable probability of serious adverse health consequences or death), Class II (temporary or medically reversible harm, or a remote probability of something more serious), or Class III (not likely to cause any adverse health consequence at all). 7.41(b) lets FDA issue a public warning about a hazard before a formal classification is even reached. At every point in that sequence, the party doing the weighing is FDA, working from its own evaluation of the firm’s product and problem — not the firm’s own account of how bad its recall is.
The evaluation has a name
FDA calls that internal work a Health Hazard Evaluation, conducted by an FDA physician alone or, for a harder call, by a committee of FDA physicians, engineers, and other scientists convened to reach a consensus. FDA runs a related but distinct tool alongside it — a Health Risk Assessment, used to estimate the harm a defective or malfunctioning device could cause rather than to classify a recall already under way. Two different FDA work products, built for two different questions, and neither one is the firm’s document to write.
The firm recalls the product. FDA grades the recall. The grading happens in a document the recall record was never built to carry.
What the enforcement record carries instead
The openFDA enforcement endpoint — one of the sources this product watches — carries the classification FDA reached: a Class I, II, or III designation, the firm, the product, and the firm’s own stated reason for the recall. It does not carry the Health Hazard Evaluation that produced the classification number sitting right next to those fields. That evaluation is FDA’s internal reasoning, not a document the enforcement record was ever designed to publish alongside its verdict.
The practice
Reading a Class I classification as self-explanatory — as if the severity rating alone said everything FDA considered — skips the step where FDA actually did the weighing 7.41(a) lays out, on facts a public enforcement record was never built to hold in full. Treating the classification number as the complete record of FDA’s reasoning, rather than as the output of a reasoning process that happened elsewhere, is a read a quality or regulatory team should not make when a classification matters enough to act on. This describes which document produces the number and which record is left holding only the number — regulatory intelligence and method, never regulatory advice about what a given classification should mean for a given supplier or product.
Primary sources
- eCFR — 21 CFR 7.3, Definitions
- eCFR — 21 CFR 7.41, Health hazard evaluation and recall classification
- FDA — Health Hazard Evaluations (HHEs) and Health Risk Assessments (HRAs)
- FDA — Recalls, Corrections and Removals (Devices)
- openFDA — Device Enforcement Reports API
- FDA Radar — what we monitor and what we deliberately don't
Regulatory intelligence, not regulatory advice. This post describes method and published FDA records as of its date; decisions about a specific device belong with your regulatory professional.